Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gitomer

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
Annals of Internal Medicine|October 20, 2025
Primary Care Physician Time Spent in Patient Care: An Observational Study Using Electronic Health Record LogsLisa S Rotenstein, Michelle Frits, Christine Iannaccone, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 15, 2021
Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility StudyGodela M Brosnahan, Wei Wang, Berenice Gitomer, et al.
BMC Nephrology|August 2, 2013
Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney diseaseJelena Klawitter, Iram Zafar, Jost Klawitter, et al.
The American Journal of Case Reports|September 2, 2025
Ex-Utero Intrapartum Treatment for a Fetal Cervical Teratoma with Mediastinal Extension: A Case ReportMadison Crew, Caitlin R Eason, Courtney Breckenfelder, et al.
International Journal of Pediatric Otorhinolaryngology|December 11, 2023
Olfactory dysfunction and training in children with COVID-19 infection: A prospective study Post-COVID pediatric olfactory trainingKenny H Chan, Bethany J Thomas, Deborah D Gilbert, et al.
Journal of Nephrology|July 22, 2022
Kynurenines in polycystic kidney diseaseJost Klawitter, Matthew J Jackson, Peter H Smith, et al.
American Journal of Nephrology|January 8, 2026
Feasibility study of empagliflozin in patients with autosomal dominant polycystic kidney disease: Design and baseline characteristicsStephen L Seliger, Wei Wang, Terry Watnick, et al.
American Journal of Physiology. Cell Physiology|January 18, 2008
CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferationClaudia R Amura, Kelley S Brodsky, Berenice Gitomer, et al.
Joint Commission Journal on Quality and Patient Safety|April 20, 2011
A two-pronged quality improvement training program for leaders and frontline staffKimberly J Rask, Richard S Gitomer, Nathan O Spell, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 27, 2019
Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled TrialKristen L Nowak, Berenice Gitomer, Heather Farmer-Bailey, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Annals of Internal Medicine|October 20, 2025
Primary Care Physician Time Spent in Patient Care: An Observational Study Using Electronic Health Record LogsLisa S Rotenstein, Michelle Frits, Christine Iannaccone, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 15, 2021
Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility StudyGodela M Brosnahan, Wei Wang, Berenice Gitomer, et al.
BMC Nephrology|August 2, 2013
Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney diseaseJelena Klawitter, Iram Zafar, Jost Klawitter, et al.
The American Journal of Case Reports|September 2, 2025
Ex-Utero Intrapartum Treatment for a Fetal Cervical Teratoma with Mediastinal Extension: A Case ReportMadison Crew, Caitlin R Eason, Courtney Breckenfelder, et al.
International Journal of Pediatric Otorhinolaryngology|December 11, 2023
Olfactory dysfunction and training in children with COVID-19 infection: A prospective study Post-COVID pediatric olfactory trainingKenny H Chan, Bethany J Thomas, Deborah D Gilbert, et al.
Journal of Nephrology|July 22, 2022
Kynurenines in polycystic kidney diseaseJost Klawitter, Matthew J Jackson, Peter H Smith, et al.
American Journal of Nephrology|January 8, 2026
Feasibility study of empagliflozin in patients with autosomal dominant polycystic kidney disease: Design and baseline characteristicsStephen L Seliger, Wei Wang, Terry Watnick, et al.
American Journal of Physiology. Cell Physiology|January 18, 2008
CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferationClaudia R Amura, Kelley S Brodsky, Berenice Gitomer, et al.
Joint Commission Journal on Quality and Patient Safety|April 20, 2011
A two-pronged quality improvement training program for leaders and frontline staffKimberly J Rask, Richard S Gitomer, Nathan O Spell, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 27, 2019
Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled TrialKristen L Nowak, Berenice Gitomer, Heather Farmer-Bailey, et al.
Pageof 18